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Ultrastructural study of florid plaques in variant Creutzfeldt–Jakob disease: a comparison with
amyloid plaques in kuru, sporadic Creutzfeldt–Jakob disease and Gerstmann-Sträussler-Scheinker
disease
Background: Although the histological features of the
amyloid plaques in variant Creutzfeldt–Jakob disease
(vCJD) are distinct from those in other forms of prion
disease [kuru, sporadic Creutzfeldt–Jakob disease (sCJD)
and Gerstmann–Sträussler–Scheinker disease (GSS)],
their ultrastructural features have only been described in a
single case report. Aims:To study vCJD plaques systemati-
cally and compare them with plaques in kuru, sCJD, GSS
and Alzheimer disease (AD). Methods: Amyloid plaques
were studied by transmission electron microscopy and
image analysis in five cases of vCJD, three cases of GSS,
two cases of sCJD, one case of kuru and five cases of AD.
Immunohistochemistry was performed on paraffin sec-
tions from one case of vCJD, two cases of GSS, one case of
kuru and two cases of sCJD. Results: The florid plaques in
vCJD were either compact or more diffuse; in both forms,
the radiating fibrils were organized into thick ‘tongues’, in
contrast to kuru plaques. Dystrophic neurites (DNs) con-
taining lysosomal electron-dense bodies or vesicles sur-
rounded florid plaques. Microglial cells were found within
florid plaques; occasional amyloid fibrils were identified in
membrane-bound pockets of microglial cells. In vCJD,
there was significant tau immunoreactivity in DNs around
florid plaques while, in sCJD, GSS and kuru, minimal tau
immunoreactivity was observed around plaques. Conclu-
sions: The ultrastructure of the florid plaques and DNs in
vCJD is more reminiscent of neuritic plaques in AD than
kuru or multicentric plaques. These findings may reflect
differences both in the strains of the transmissible agents
responsible for these disorders and in host factors.
Keywords: amyloid, Gerstmann–Sträussler–Scheinker disease, kuru, plaque, prion protein, sporadic Creutzfeldt–Jakob
disease, variant Creutzfeldt–Jakob disease, ultrastructure
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Introduction
Amyloid plaques are a hallmark of transmissible and
non-transmissible brain amyloidoses. The former com-
prise transmissible spongiform encephalopathies (TSEs) or
prion diseases, which include kuru [1], Creutzfeldt–Jakob
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disease (CJD) [2], Gerstmann–Sträussler–Scheinker
disease (GSS) [3,4] and fatal familial insomnia (FFI) [5].
There are also animal diseases – scrapie in sheep and goats
[6], transmissible mink encephalopathy [7], chronic
wasting disease (CWD) in deer and elk [8–10], and bovine
spongiform encephalopathy (BSE) [11]. Of the non-
transmissible amyloidoses, Alzheimer’s disease (AD) [12]
and familial British dementia [13] are best recognized.
Human TSEs occur as sporadic, hereditary and infec-
tious (iatrogenic) disorders [14,15]. CJD is a sporadic dis-
order (sCJD) in around 85% of cases; some 10–15% of CJD
cases are hereditary, linked to over 20 mutations in the
prion protein gene (PRNP); and the remaining cases are
iatrogenic following neurosurgical procedures, adminis-
tration of human growth hormone and gonadotrophins,
and corneal or dura mater transplants [16]. Other familial
forms of human TSEs include FFI and GSS. In 1996, a new
variant form of CJD (now known as ‘variant’ CJD, or vCJD)
was discovered, which results from exposure to BSE, prob-
ably by the oral route [17].
Amyloid plaques are restricted to certain subsets of
human prion diseases: in sCJD, amyloid plaques occur in
approximately 10–15% of cases that have been character-
ized as the MV2 subtype, according to the codon 129
polymorphism in the PRNP gene and the isoform of the
disease-associated prion protein found on Western blot
analysis of the brain [18]. These plaques closely resemble
those seen in all cases of kuru (hence, kuru plaques)
[19,20], but are structurally distinct at the light micro-
scopic level from the florid plaques in vCJD [21] and the
multicentric plaques in GSS [3,4,22]. There are no
plaques in FFI; indeed, there are only relatively mild
pathological changes in FFI anyway. In prion diseases in
animals, amyloid plaques are common in different strains
of rodent scrapie [23] and occur in all cases of CWD in
mule deer [10]. In scrapie in sheep, they are only rarely
present, and are absent in BSE in cattle; however, one
recent novel form of cattle TSE reported in Italy (bovine
amyloidotic spongiform encephalopathy or BASE) is char-
acterized by amyloid plaques in the brain [24]. Most cases
of ruminant TSE infections do not give rise to amyloid
plaques.
The ultrastructure of kuru and multicentric plaques
has been studied for decades, but the florid plaques that
are characteristic of vCJD have been described at the
ultrastructural level in only one case report [25]. To
rectify this situation, we studied vCJD plaques systemati-
cally by light and electron microscopy and compared them
with plaques in sCJD, GSS, kuru and AD. The hypothesis
for this study is that vCJD amyloid plaques possess ultra-
structural features different from amyloid plaques occur-
ring in other human prion diseases; these ultrastructural
differences are reflected in their unique light microscopic
appearances.
Material and methods
Five cases of vCJD, three cases of GSS (one autopsy and
two biopsy specimens), two cases of sCJD with plaques and
one case of kuru [20] were used in this study. The clinical
data of the vCJD cases are summarized in Table 1. One
GSS case belonged to the original Austrian ‘H’ family
[4,22]; the remaining two cases belonged to the German
‘Sch’ family, which has been previously described [26,27].
Both Austrian and German GSS families were carriers of
102Leu mutation in the PRNP gene; the codon 129 was
homozygous for methionine in both the Austrian case and
German cases [4,16,28]. All GSS cases fulfilled the neuro-
pathological diagnostic criteria of Budka et al. [29]. Both
of the sCJD cases were heterozygous at codon 129 in the
PRNP gene. We also used archival brain specimens of a
16-year-old man who died from kuru in 1968 [20].
Furthermore, we studied five well-preserved biopsy and
autopsy specimens of Alzheimer disease (AD) from the
files of Department of Molecular Pathology and Neuropa-
thology, Medical University, Lodz, Poland.
For electron microscopy, approximately 2-mm3 samples
of grey matter from different brain regions were prepared.
Table 1. Basic clinical data on variant Creutzfeldt–Jakob disease (vCJD) cases
VCJD cases 96/02 96/03 96/07 96/45 96/110
Age (years) 41 29 30 31 35
Duration (months) 18 23 18 9 14
Sex F F F M F
PRNP codon 129 genotype MM MM MM MM MM
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From vCJD, and the GSS case from the H family, we always
studied at least four regions – frontal, temporal, occipital
cortices and the cerebellum. Wherever possible, four
blocks were studied from every region and at least two
grids were prepared from every block. From the vCJD
cases, we studied collectively 50 blocks. From the brain
biopsy of the GSS case from the Sch family, only the frontal
cortex was available. From the kuru case, one block from
the frontal cortex and one block from cerebellum were
studied. From the remaining cases, only single blocks were
available. The tissue blocks were immersion-fixed in 2.5%
glutaraldehyde for less than 24 h, embedded in Epon and
routinely processed for electron microscopy; from a kuru
case and one of the sCJD cases, material was reprocessed
for electron microscopy from formalin-fixed paraffin-
embedded blocks as described previously [30]. Grids were
examined and photographed in JEOL JEM 100 CX and
JEOL JEM 1011 transmission electron microscopes at
80 kV. Analysis of fibril diameter was performed using
iTEM Soft Imaging System for transmission electron
microscopy, Olympus, Japan and the diameters of 100
fibrils were measured in each case. For statistical analysis,
only cases fixed in glutaraldehyde were included. A non-
parametric Mann–Whitney U-test was used to compare
group mean values for fibril diameters.
Additionally, we performed immunohistochemistry on
paraffin sections of the frontal cortex and cerebellum from
one vCJD case, two sCJD cases, two GSS cases and one
kuru case. All the paraffin blocks used for immunohis-
tochemistry were obtained from autopsy brain tissue, rou-
tinely fixed in 4% formaldehyde and embedded in paraffin.
Antibodies used in the study are described in Table 2. For
visualization of all immunolabelling, the LSAB+ Kit with
horseradish peroxidase (DAKO, Ely, Cambridgeshire, UK)
was used.
Results
Plaques in specimens of GSS and sCJD were of two major
types: the first was stellate unicentric kuru plaques com-
posed of a dense centre of interwoven fibrils and radiating
fibrils at the periphery, and they were seen in both GSS and
sCJD (Figure 1). The second type was found only in GSS
specimens – multicentric plaques composed of several
merging unicentric plaques (Figure 2). A particular
plaque type – unicentric stellate amyloid plaques (florid
plaques) – were readily identified in all vCJD specimens
(Figure 3); they were most abundant in the occipital
cortex and the cerebellum. These were either compact
(resembling kuru plaques) or more diffuse; even in the
more compact plaques, the radiating fibrils were orga-
nized into thick ‘tongues’ in contrast to kuru plaques. Irre-
spective of the region studied, no obvious differences were
seen in the general ultrastructural features of the plaques
in vCJD. The radiating tongues of amyloid that give the
florid plaque a stellate appearance were also thicker than
those in GSS and vCJD. It was noteworthy that, apart from
florid plaques, smaller amyloid (fibrillar) structures –
which have been called cluster plaques – were also seen in
vCJD; however, it is impossible to be sure that those are not
the poles of larger plaques cut tangentially. Numerous
empty vacuoles were seen within and around florid
plaques, which appeared as rather dilated ‘empty’ pro-
cesses (as judged by remnant of subcellular organelles like
mitochondria within them) and not typical ‘spongiform’
vacuoles. The latter term is used to describe ‘empty’ spaces
containing curled membrane fragments and ‘fluffy’ mate-
rial [31]. Thus, the nature of vacuoles surrounding florid
plaques remains uncertain.
To demonstrate differences in amyloid fibril thickness,
we performed analysis of fibril diameter using a morpho-
Table 2. Antibodies used for immunohistochemistry on paraffin sections
Antigen Company Clone Host Dilution
HLA DR DAKO CR3/43 Mouse IgG1 1 : 100
GFAP DAKO Polyclonal Rabbit 1 : 3000
APP Chemicon 22C11 Mouse IgG1 1 : 500
NFP DAKO 2F11 Mouse IgG1 1 : 50
Tau Pierce endogen AT8 Mouse IgG1 1 : 200
PrP Cayman 12F10 Mouse IgG2a 1 : 500
Ubiquitin DAKO Polyclonal Rabbit 1 : 200
HLA DR, human leucocyte antigen DR; GFAP, glial fibrillary acidic protein; APP, amyloid precursor protein; NFP, neurofilament protein.
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Figure 1. Gerstmann–Sträussler–Scheinker disease. (a, b, c) Different views of amyloid plaques. Note that some plaques are surrounded by
a pale ‘halo’ composed of astrocytic processes (c, arrowheads). (c) Dystrophic neurites around a plaque (arrows).
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metric system for transmission electron microscopy by
measuring the diameters of 100 fibrils in every case. The
mean diameter of a single fibril in GSS was 17.64 nm
(range 12–22.99 nm) while, in vCJD, it was 21.37 nm
(range 17.23–24.37 nm) and in AD – 14.24 nm (range
11.41–17.35 nm). As normality assumption for data
distribution was not met for the AD and vCJD groups
(Shapiro–Wilk W test significant) and variances could not
be assumed as equal (Levene’s test for equality of vari-
ances significant for all three between groups compari-
sons), a non-parametric Mann-Whitney U-test was used
to compare groups’ means as a post hoc procedure after a
Kruskal–Wallis one-way analysis of variance (c2 = 215.2;
df = 2, P < 0,001).
In GSS, the mean value for fibril diameter
(17.6  2.5 nm) was significantly larger than in AD
(14.2  1.4 nm), Mann–Whitney U-test, P < 0.001.
In vCJD, the group mean value (21.4  1.8 nm) was
significantly bigger than in both GSS (P < 0.01) and AD
(P < 0.001). Thus, the statistical analysis showed signifi-
cant differences between these groups. The mean values
for fibril diameters in kuru plaques in cases of kuru and
sCJD were 23.40 and 27.06 nm, respectively, although
these values were not statistically analysed due to the
changes evoked by different fixation conditions from vCJD,
GSS and AD cases. Fibrils from amyloid material retrieved
from paraffin blocks are usually much thicker than in cor-
responding material directly fixed in glutaraldehyde;
e.g. in GSS plaques, the fibril diameter from paraffin-
embedded tissues is approximately 50 nm, approximately
three times more than from the non-paraffin-embedded
material. From these observations, we may therefore
speculate that the real diameter of amyloid fibrils in kuru
plaques from a case of kuru may be around 7–8 nm, con-
sistent with data already published from material directly
fixed in glutaraldehyde, which give a fibril diameter of
7 nm [32].
Interestingly, florid plaques were neuritic – i.e. they con-
tained dystrophic neurites; the latter contained lysosomal
electron-dense bodies or vesicles (Figure 3). Dystrophic
neurites (DNs) were found either at the margin of plaques
or immersed within the centre of the plaque. In the non-
a b
Figure 2. Amyloid plaques in (a) variant Creutzfeldt-Jakob disease (vCJD) in comparison to (b) Gerstmann–Sträussler–Scheinker disease.
Note the vacuoles (arrowheads) around the vCJD plaque (a).
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florid plaques of vCJD, DNs were also observed, mainly at
the plaque margins. Microglial cells (Figure 4), not unlike
those in GSS [33], were found within vCJD plaques and, in
certain specimens, amyloid fibrils were clearly present in
membrane-bound pockets of microglial cells. In two speci-
mens from the temporal cortex in vCJD, Hirano bodies
were found in cell processes in the neuropil close to florid
plaques (Figure 5). In kuru, astrocytic processes were fre-
quently seen at the margin of plaques. The ultrastructural
differences between the various types of plaques are illus-
trated in Figure 6 and summarized in Table 3.
Recently, we realized that autophagy is an important
contributor to the pathology of TSEs [34,35]. To this end,
we observed many multivesicular bodies, which are
involved in the process of microautophagy, in the vCJD
cases [36]. Those subcellular organelles were often found
within electron-lucent vacuoles of different sizes located
at the margin of florid plaques (Figure 7). In AD, the
ultrastructure of amyloid plaques was similar to that in
earlier descriptions [37], with dense amyloid cores sur-
rounded by corona of DNs; in contrast to the DNs of TSEs,
those in AD contained paired helical filaments (PHFs).
a
c
b
Figure 3. Variant Creutzfeldt–Jakob disease (vCJD). Lower (a) and higher (b) magnifications of amyloid plaques. Note that the florid plaque
in vCJD is more ‘diffuse’ than specimens in Figures 1–2. (c) A dystrophic neurite (arrow) with dense lysosomal bodies (arrowhead).F, amyloid
fibrils.
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Figure 4. Variant Creutzfeldt–Jakob disease. Dense cytoplasm of a
microglial cell within an amyloid plaque. Note the large electron-
lucent vacuoles within the cytoplasm of the microglial cell.
Figure 5. Variant Creutzfeldt–Jakob disease. A typical Hirano body
in a cell process adjacent to a florid plaque.
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Figure 6. Comparison of plaque ultrastructure in (a) variant Creutzfeldt–Jakob disease (vCJD), (b) Gerstmann–Sträussler–Scheinker disease
and (c) Alzheimer’s disease. Amyloid is labelled by arrows in (c) and (d), the latter also showing a dystrophic neurite (DN) in vCJD.
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While the search for tubulovesicular structures (TVSs),
the only disease-specific particles found in all TSEs at the
level of electron microscopy [38], was not the aim of this
study, we readily found them in all GSS specimens [39],
but not in autopsy vCJD specimens. In contrast, TVSs
were previously readily found in a brain biopsy vCJD
specimen [40].
Immunohistochemistry for glial fibrillary acidic protein
(GFAP) showed astrocytosis in all cases in both cerebral
and cerebellar cortex. In the cerebellum, astrogliosis was
most pronounced in the kuru case. The GFAP-positive cell
processes were observed around the plaques and in the
peripheral part of the plaques in kuru and, to a lesser
degree, in sCJD. In vCJD and GSS, the astrocytic processes
surrounded the plaques, but did not penetrate into the
plaques. Immunohistochemistry for human leucocyte
antige DR (HLA-DR) revealed the presence of HLA-DR-
positive microglial cells around the plaques in all cases. In
GSS and vCJD, there was also significant HLA-DR immu-
noreactivity in the central parts of the plaques. Immuno-
histochemistry for amyloid precursor protein (APP)
showed high numbers of APP-positive structures corre-
sponding to DNs around the plaques in vCJD and GSS. In
kuru and sCJD, we also observed some APP-positive dis-
tended processes, but they were dispersed throughout
cortex and not gathered around the plaques. Immunohis-
tochemistry for ubiquitin also revealed DNs at the plaque
margin as well as some dispersed abnormal neurites in
vCJD and in GSS. In kuru and sCJD, the number of
ubiquitin-positive DNs was much lower and the intensity
of staining for ubiquitin around the plaques was less
intense (Figure 8). Similar results were obtained following
immunohistochemistry for phosphorylated neurofila-
ment proteins (NFP), which also demonstrated some
axonal swellings in the cerebellar cortex in both vCJD and
GSS. These structures were distributed randomly, not
around the plaques. An interesting observation was made
on immunohistochemistry for hyperphosphorylated tau
with the AT8 anti-tau antibody. In vCJD, there was signifi-
cant immunoreactivity in DNs around the plaques and
some AT8-positive structures were also dispersed in the
cerebral and, to a lesser degree, the cerebellar cortex
(Figure 9a). In sCJD, GSS and kuru, immunoreactivity for
tau was much less intense and was restricted to the
periphery of the plaques, but not in the neuropil
(Figure 9b–d).
Discussion
We describe herein the spectrum of amyloid plaques in
vCJD. The most characteristic plaques of vCJD are florid
plaques – stellate structures surrounded by vacuoles,
visible in haematoxylin and eosin sections in light micros-
copy. Those plaques differ from unicentric kuru plaques of
sCJD and multicentric plaques of GSS. Florid plaques are
also unicentric, but they were of a less compact structure
than kuru plaques, with constituent amyloid fibrils being
thicker than those of sCJD/GSS. The diameter of the single
fibril of a florid plaque measured in situ is much higher
than in the amyloid plaques of GSS or AD. Merz et al. [41]
showed that fibrils isolated from AD brain were 4–8 nm in
diameter and fibrils from GSS brain were 7–9 nm. Those
results also showed that AD fibrils are thinner in compari-
son with GSS. The differences between our numbers and
those showed in Merz et al.’s [41] paper are most probably
evoked by the different methodology of experiments (iso-
lation and negative staining vs. fixed tissues and positive
staining).
As in the plaques of GSS, but unlike most plaques of
sCJD, florid plaques are neuritic – they contain DNs accu-
mulating electron-dense lysosomal bodies and vesicles,
Figure 7. Vacuoles around a plaque contain multivesicular body
(arrows) in variant Creutzfeldt–Jakob disease. F, amyloid fibrils.
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but many of these abnormal structures are mixed with
amyloid fibrils. Thus, a subpopulation of DNs are situated
not at the periphery of the plaque, but more often within
the centre. The latter situation is not unusual in AD,
where in a reconstruction of plaques using confocal laser
microscopy, Masliah et al. [42] elegantly demonstrated
that DNs are located at the plaque centre and their spuri-
ous location at the periphery reflects the plane of the
section, not the real plaque structure. The plaque pathol-
ogy in vCJD may, however, reflect the latter situation, as
there are many more plaques in vCJD than in sCJD or even
GSS, and thus there are more planes at which these
plaques are sectioned for electron microscopy. In any case,
the problem of whether small DNs within the plaque
centre is an intrinsic characteristic of the florid plaque of
vCJD, as already suggested in a case report from France
[25], or an artefact of sectioning, requires computer-
based image analysis for final elucidation. The ultrastruc-
ture of florid plaques of vCJD is reminiscent of neuritic
plaques in AD, in spite of the obvious difference that a
proportion of DNs in AD contain PHFs. It must be stressed,
however, that a high proportion of DNs in AD do not
contain PHFs [43].
The presence of neuritic dystrophy and occasional
Hirano bodies in processes around the florid plaques of
vCJD suggests that they might represent a neuronal reac-
tion to the abnormal accumulation of amyloid. However,
these changes are not present around other forms of PrP
amyloid plaques, suggesting that differences in the confor-
mation and arrangement of the amyloid fibres in different
Figure 8. Hyperphosphorylated tau immunoreactivity around amyloid plaques in human TSEs in structures that appear to be dystrophic
neurites (AT8 anti-tau antibody with haematoxylin counterstain, ¥600). (a) Variant Creutzfeldt–Jakob disease; (b) sporadic Creutzfeldt–Jakob
disease; (c) Gerstmann–Sträussler–Scheinker disease; (d) kuru.
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forms of human prion disease may influence these reac-
tions, or that there are other plaque constituents in vCJD
that potentiate the neuronal reaction. Previous studies
have suggested that tau accumulates within neuritic
processes around plaques in some human prion diseases,
including vCJD [44] and GSS [45]; on the other hand, the
DNs in sCJD have been previously reported to accumulate
NFP rather than tau [46].
Our immunohistochemical studies confirmed the
presence of microglial cells, astrocytic processes and
dystrophic neurites at the periphery of the plaques.
Immunoreactivity with the AT8 antibody revealed hyper-
phosphorylated tau at periphery of the plaques in vCJD, in
a distribution that is consistent with DNs. This finding is
also reminiscent of AD plaques but, in contrast to AD, no
PHF were observed within DNs in vCJD on electron micros-
copy. In contrast to a previous report [44], tau immunore-
activity in or around the plaques in kuru, GSS and sCJD
was also observed. This difference is probably due to the
lack of plaques in sCJD cases studied by Giaccone et al.
[44]. To our knowledge, this is the first report on hyper-
phosphorylated tau immunoreactivity in sCJD and kuru.
All our GSS and vCJD cases were homozygous for
methionine at codon 129 of the PRNP gene. Thus, we
cannot conclude that the differences in plaque ultrastruc-
ture result from differences in PRNP codon 129 polymor-
phism as suggested by Cervenakova et al. [47]. All
described kuru cases with plaques were homozygous for
methionine or for valine [47,48]. However, the number of
studied kuru cases was small, and the influence of the
presence of valine at codon 129 on the clinical course and
pathology of prion diseases require further investigation.
Figure 9. Differing patterns of ubiquitin immunoreactivity around amyloid plaques in human transmissible spongiform encephalopathies
in neurites and in thread-like structures in the surrounding neuropil (anti-ubiquitin antibody with haematoxylin counterstain, ¥ 600).
(a) Variant Creutzfeldt–Jakob disease; (b) sporadic Creutzfeldt–Jakob disease; (c) Gerstmann–Sträussler–Scheinker disease; (d) kuru.
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In conclusion, we can say that there are three types of
amyloid plaques in vCJD observed by light microscopy:
florid plaques, small kuru plaques (cluster plaques) and
amorphous plaques. Ultrastructurally, all consist of thick
amyloid fibrils, different from the amyloid fibrils seen in
other human prion diseases. The florid plaques are not
only surrounded by vacuoles, but also contain DNs,
microglial cells and occasional Hirano bodies at their
border; thus, the ultrastructural composition of florid
plaques in vCJD is reminiscent of Ab laques in AD, but
their fibrils are significantly thicker. The DNs around the
plaques in vCJD contain APP, ubiquitin, hyperphosphory-
lated tau and phosphorylated NFP; the number of tau-
positive DNs around florid plaques was higher than any of
the amyloid plaques in GSS, kuru and sCJD.
The reasons why florid plaques differ in structure
from kuru plaques and multicentric plaques observed in
sCJD, kuru and GSS are open to speculation. The strain of
TSE agent that causes vCJD is different from those of
sCJD and kuru, and closely resembles the BSE agent
[49–51]. It has been shown for decades that quantitative
TSE neuropathology is under strict control of both the
host PRNP genotype and the strain of the agent, and the
amount of amyloid in the form of plaques is one of those
characteristics [52]. However, the ultrastructural pathol-
ogy is the same ‘kuru plaque’ irrespective of the experi-
mental model selected [53]. Thus, the strain difference
influences quantitative characteristics of amyloid
plaques, but not necessarily their ultrastructural appear-
ance. In sCJD, kuru plaques are characteristically con-
fined to cases that are heterozygous at codon 129 in the
PRNP gene (as in our cases) [18]. Furthermore, the
agent that causes vCJD is also the cause of BSE in cattle,
which is characterized by a virtual absence of amyloid
plaques in the brain [43], further highlighting the impor-
tance of host factors in the pathological phenotype of
this group of disorders.
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